These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18613893)

  • 1. Contact pemphigus: a side-effect of imiquimod therapy.
    Lo Schiavo A; Sangiuliano S; Puca RV; Brunetti G; Ruocco E; Cozzi R
    Int J Dermatol; 2008 Jul; 47(7):765-7. PubMed ID: 18613893
    [No Abstract]   [Full Text] [Related]  

  • 2. Imiquimod contact pemphigus: a comment.
    Ruocco E; Baroni A; Rossiello L; Ruocco V
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):242-3. PubMed ID: 15262368
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment.
    Mashiah J; Brenner S
    Arch Dermatol; 2005 Jul; 141(7):908-9; author reply 909. PubMed ID: 16027316
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect.
    Campagne G; Roca M; Martínez A
    Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):224-7. PubMed ID: 12860347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus.
    Sebaratnam DF; Martin LK; Rubin AI; Tran K; Pas HH; Marr PJ; Edmonds J; Murrell DF
    Clin Exp Dermatol; 2011 Jan; 36(1):91-3. PubMed ID: 20819088
    [No Abstract]   [Full Text] [Related]  

  • 6. Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata.
    Dede M; Kubar A; Yenen MC; Alanbay I; Guven S; Mesten Z; Baser I
    Acta Obstet Gynecol Scand; 2007; 86(8):968-72. PubMed ID: 17653883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of vulvar intraepithelial neoplasia with topical imiquimod.
    van Seters M; van Beurden M; ten Kate FJ; Beckmann I; Ewing PC; Eijkemans MJ; Kagie MJ; Meijer CJ; Aaronson NK; Kleinjan A; Heijmans-Antonissen C; Zijlstra FJ; Burger MP; Helmerhorst TJ
    N Engl J Med; 2008 Apr; 358(14):1465-73. PubMed ID: 18385498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine.
    Fine JD; Appell ML; Green LK; Sams WM
    Arch Dermatol; 1988 Feb; 124(2):236-9. PubMed ID: 3277542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigus treatment with azathioprine. Clinical and immunologic correlation.
    Roenigk HH; Deodhar S
    Arch Dermatol; 1973 Mar; 107(3):353-7. PubMed ID: 4571038
    [No Abstract]   [Full Text] [Related]  

  • 10. Erosive pustular dermatosis of the scalp following treatment with topical imiquimod for actinic keratosis.
    Vaccaro M; Barbuzza O; Guarneri B
    Arch Dermatol; 2009 Nov; 145(11):1340-1. PubMed ID: 19917978
    [No Abstract]   [Full Text] [Related]  

  • 11. Human papillomavirus isolated from transplant-associated porokeratoses of mibelli responsive to topical 5% imiquimod cream.
    Esser AC; Pittelkow MR; Randle HW
    Dermatol Surg; 2006 Jun; 32(6):858-61. PubMed ID: 16792657
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pemphigus herpetiformis].
    Katz M; Holubar K
    Hautarzt; 1984 Sep; 35(9):478-80. PubMed ID: 6384140
    [No Abstract]   [Full Text] [Related]  

  • 13. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
    Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of verruciform xanthoma with imiquimod.
    Guo Y; Dang Y; Toyohara JP; Geng S
    J Am Acad Dermatol; 2013 Oct; 69(4):e184-6. PubMed ID: 24034392
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced IgG anti-desmocollin autoantibody titre and concomitant improvement in a patient with pemphigus vegetans.
    Tani N; Sugita K; Yamada N; Ishii N; Hashimoto T; Yamamoto O
    Eur J Dermatol; 2018 Apr; 28(2):232-233. PubMed ID: 29336313
    [No Abstract]   [Full Text] [Related]  

  • 16. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
    Heaphy MR; Albrecht J; Werth VP
    Arch Dermatol; 2005 Jun; 141(6):699-702. PubMed ID: 15967915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Painful ulceration of the vulva.
    Gómez Moyano E; Ayala Blanca M; Martínez Pilar L
    Am J Obstet Gynecol; 2019 Oct; 221(4):359-360. PubMed ID: 30690013
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of invasive squamous cell carcinoma using topical imiquimod.
    Hengge UR; Schaller J
    Arch Dermatol; 2004 Apr; 140(4):404-6. PubMed ID: 15096367
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of pemphigus vulgaris possibly triggered by quinolones.
    Anadolu RY; Birol A; Bostanci S; Boyvatt A
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):152-3. PubMed ID: 12046820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized pemphigus foliaceus induced by topical imiquimod treatment.
    Lin R; Ladd DJ; Powell DJ; Way BV
    Arch Dermatol; 2004 Jul; 140(7):889-90. PubMed ID: 15262711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.